Compare PCG & CNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PCG | CNC |
|---|---|---|
| Founded | 1995 | 1984 |
| Country | United States | United States |
| Employees | 29000 | N/A |
| Industry | Power Generation | Medical Specialities |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 36.0B | 32.1B |
| IPO Year | N/A | 2001 |
| Metric | PCG | CNC |
|---|---|---|
| Price | $17.10 | $67.17 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 16 |
| Target Price | $22.19 | ★ $46.75 |
| AVG Volume (30 Days) | ★ 17.5M | 4.0M |
| Earning Date | 04-23-2026 | 04-28-2026 |
| Dividend Yield | ★ 1.22% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 3.11 |
| Revenue | N/A | ★ $194,777,000,000.00 |
| Revenue This Year | $7.24 | $8.31 |
| Revenue Next Year | $3.41 | $1.05 |
| P/E Ratio | ★ $15.15 | $21.99 |
| Revenue Growth | N/A | ★ 19.44 |
| 52 Week Low | $12.97 | $25.08 |
| 52 Week High | $19.16 | $68.41 |
| Indicator | PCG | CNC |
|---|---|---|
| Relative Strength Index (RSI) | 54.88 | 64.32 |
| Support Level | $17.00 | $33.27 |
| Resistance Level | $18.94 | N/A |
| Average True Range (ATR) | 0.33 | 2.17 |
| MACD | 0.02 | 0.00 |
| Stochastic Oscillator | 68.20 | 79.77 |
PG&E is a holding company whose main subsidiary is Pacific Gas and Electric, a regulated utility operating in Central and Northern California that serves 5.3 million electricity customers and 4.6 million gas customers in 47 of the state's 58 counties. PG&E operated under bankruptcy court supervision in 2001-04 during California's energy crisis and in 2019-20 due to wildfire losses. In 2004, PG&E sold its unregulated assets as part of its first postbankruptcy reorganization.
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 20 million medical members as of December 2025, mostly in Medicaid (about 64% of membership), the individual exchanges (about 28%), and Medicare (about 5%). The company also provides Medicare Part D pharmaceutical plans.